1 / 7

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63. Characteristics of selected major statin trials. Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63. Updated meta-analysis of major statin trials that assessed the effect of statins on fatal and non-fatal stroke.

violet-pope
Télécharger la présentation

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

  2. Characteristics of selected major statin trials Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

  3. Updated meta-analysis of major statin trials that assessed the effect of statins on fatal and non-fatal stroke Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

  4. Updated meta-analysis of major statin trials that assessed the effect of statins on fatal stroke Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

  5. Updated meta-analysis of major statin trials that assessed the effect of statins on haemorrhagic stroke Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

  6. Association between reduction in LDL cholesterol concentration with stroke incidence among the major statins trials Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

  7. Meta-analysis of statin trials that assessed the effect of intensive lipid-lowering therapy versus standard statin therapy on incidence of fatal and non-fatal stroke and on major cardiovascular events Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

More Related